Standardisation of syndrome differentiation and exploring Chinese herbal medicine use for early breast cancer

Phase 1

Completed

• Conditions: Breast cancer

• Registration Number: ITMCTR2000003264
• Lead Sponsor: Guangdong Provincial Hospital of Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2023-02-20

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

1. Patients whose pathology meets the diagnostic criteria of early breast cancer (stage I-III, excluding distant metastasis);
2. Female patients over 18 years old (including 18 years old);
3. Patients with a score of 0-2 in ECoG (Eastern Cooperative Oncology Group);
4. Patients who voluntarily participated in the study and signed informed consent.

Exclusion Criteria

1. Patients with severe cardiovascular and cerebrovascular diseases or mental related diseases;
2. Patients who receive neoadjuvant therapy or chemotherapy, radiotherapy and endocrine therapy at the same time;
3. Pregnant or lactating women.

Study & Design

• Study Type: Observational study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
symptoms, signs, syndromes and application of traditional chinese medicine;